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Abstract
Eleven analogues of nifedipine (NP) showed synergistic interactions with ampicillin (Ap) and erythromycin (Er) on Escherichia
coli K12LE140/F’lac. The antibacterial effect of Ap was enhanced by most analogues but compound (G9) and (9/)-verapamil (VP)
were antagonistic. Two of the 11 compounds (G7, G8) were synergistic with Er and four were additive. With a sensitive clinical
isolate of E . coli Gy-1/ApsensErres, compound G1 antagonized the antibacterial effect of Ap and a synergistic effect was found in the
combination of Er with G4, G5, G6 or G7. None of the drugs had any effect on a multidrug resistant (MDR) clinical isolate of
E . coli Gy-2/ApresErres. # 2002 Elsevier Science B.V. and International Society of Chemotherapy. All rights reserved.
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1. Introduction
Various studies have been made to increase the
efficiency of antimicrobial agents. A combination of
methdiazine (Md) a phenothiazine derivative and strep-
tomycin (Sm), ampicillin (Ap), erythromycin (Er) or
tetracycline (Tc) was synergistic against Vibrio cholerae
14033 [1]. Similarly, significant synergism was found
between promazine (Pr), a phenothiazine derivative
possessing antimicrobial activity, and Sm, Ap and Er
or Tc against Salmonella typhimurium NCTC 74 infec-
tion in mice [2].
In a previous study, we found that (9/)-verapamil
(VP) plus promethazine were effective resistance modi-
fiers on a laboratory strain of Escherichia coli by
plasmid elimination [3].
The resistance modifier effect of VP is seen in bacteria
[4], fungi [5,6], protozoa [7] and cancer cells [8] but
adverse effects occurred. To improve specificity, new
nifedipine (NP) analogues were synthesized on the basis
of previous results [9] and tested on a laboratory strain
of E. coli and two clinical isolates. The interaction
between antibiotics and newly synthetized NP analogues
were studied and evaluated by the chequerboard test.
2. Materials and methods
2.1. Chemicals
Eleven acetyldihydropyridines AcDHP (G1/11) of
NP analogue were synthesized as previously described
[9] (Fig. 1).
2.2. Antibiotics and resistance modifiers
The following antibiotics were obtained from the
companies indicated: Ap (Beechaem Research Labora-
tories, England); Er (Richter Gedeon RT, Budapest,
Hungary).
The resistance modifiers were obtained from the
companies indicated; (9/)-VP (Chinoin, Budapest, Hun-
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PII: S 0 9 2 4 - 8 5 7 9 ( 0 2 ) 0 0 1 5 9 - 0
gary); NP (Aldrich Chemical Co., Inc., Milwaukee, WI,
USA).
2.3. Bacterial strains
A laboratory strain of E . coli K12LE140/F’lac and
two clinical isolates (E . coli Gy-1/ApsenErres and E . coli
Gy-2/ApresErres) were kindly provided by the public
health institute of Csongrad county.
2.4. Measurement of antibacterial activity
The antibacterial effect of the tested compounds was
studied in modified minimal tryptone yeast extract
(MTY) liquid media [4], containing 1.0 g NH4Cl, 7.0 g
K2HPO4, 3.0 g NaH2PO4, 0.8 g NaCl, 1.0 g D-glucose,
10.0 g Bacto trytone (Difco) and 1.0 g yeast extract
(Difco) in 1.0 l distilled water at pH 7.2.
An overnight preculture of the laboratory strain and
two clinical isolates of E . coli were diluted 104-fold
and 0.1 ml (ca. 5/103 bacteria) was inoculated into 5.0
ml of MTY broth containing various concentrations of
the different compounds. The cultures were grown at
37 8C without shaking. Minimum inhibitory concentra-
tions (MIC) were read after 24 h incubation.
Three bacterial strains were tested by the microdilu-
tion chequerboard technique described by Eliopoulus
and moellering [10]. Briefly, bacterial dilutions from the
logarithmic-growth phase were prepared and subse-
quently distributed into micrometer trays containing
various drug regimen concentrations. The final inocu-
lum size in the micrometer trays was approximately 105
colony forming unit (CFU)/ml.
Inoculated micrometer trays were incubated at 37 8C
for a period of 24 h and were then read for inhibition of
bacterial growth. In order to evaluate the outcome of
the drug combination, fractional inhibitory concentra-
tion (FIC) indices were calculated as FICA/FICB,
when FICA and FICB represent the minimum concen-
trations that inhibited inoculum growth for drugs A and
B, respectively [9]. Individual chequerboard runs were
replicates, a mean FIC index was calculated and applied
to a commonly utilized definition of synergy, and
classified as either synergistic (5/0.5), additive (0.51/
1.0), indifferent (1.01 but 5/4.0), or antagonistic (above
4.0) (Table 1).
Table 1




AMP ERY AMP ERY Ap Er
Antibiotic alone 4 8 8 64 256 64
G1 1 8 64 32 64 64
G2 2 4 8 32 64 64
G3 1 4 8 32 64 64
G4 1 8 8 16 64 64
G5 2 8 8 16 64 64
G6 2 8 8 16 64 64
G7 1 2 8 16 64 64
G8 1 2 8 32 64 64
G9 8 8 8 32 64 64
G10 1 4 8 32 64 64
G11 1 4 8 32 64 64
(9)-VP 32 4 4 32 64 64
NP 2 4 8 32 64 64
Fig. 1. Structures of 3,5-diacetyl-1,4-dihydropyridines (G1/11), (9/)-
VP and NP.
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3. Results and discussion
3.1. Antibacterial activity of Ap, AcDHP (G1/11), VP,
NP and Er
MIC values of AcDHP after 24 h were measured on
three different E . coli strains and the results are shown
in Table 1. No antibacterial effect was seen by the non-
antibiotics up to a concentration of 100 mg/ml. Table 1
shows the results of the chequerboard studies.
3.2. Combination effect of AcDHP (G1/11) with Ap
A synergistic effect of AcDHP was seen with Ap
against E . coli K12LE140/F’lac after 24 h, when
combination with seven AcDHP reduced the Ap MIC
to 1 mg/l and the MIC of NP to 2 mg/l. Two compounds
G9 (MIC/8 mg/l) and VP (MIC: 32 mg/l) were less
effective than the others. The most effective compounds
were as follows: G1, G3, G4, G7, G8, G10 and G11.
The MICs of Ap against a clinical isolate (E . coli Gy-
1/ApsensErres) after 24 h with combination of G1 were
antagonistic (MIC for Ap 64 mg/l) (Table 1). Ten other
AcDHP (G1/11) (MIC: 8 mg/l) and NP (MIC: 8 mg/l)
were not synergistic and only VP (MIC: 4 mg/l) had an
additive effect.
3.3. Combination effect of AcDHP (G1/11) with Er
AcDHP (G1/11) had a synergistic effect with Er
against E . coli K12LE140/F’lac after 24 h, the MICs of
G7 (MIC: 2 mg/l) and G8 (MIC: 2 mg/l) were synergistic
whereas the MIC values of G2, G3, G10, G11, VP and
NP were additive (4 mg/l). The compounds G1, G4, G5,
G6 and G9 were ineffective in combination with Er
against E . coli K12LE140/F’lac strain (Table 1). Com-
pound G7 was the most effective of the eleven AcDHP
(G1/11), VP and NP with Ap or Er against E . coli
K12LE140/F’lac after 48 h (Table 1).
Combination of Er with eleven AcDHP (G1/11)
(MIC: 16/32 mg/l), VP (MIC: 32 mg/l) and NP (MIC:
32 mg/l) had no effect on the MIC of Er (Table 1).
The combinations of AcDHP (G1/11) with the two
antibiotics against clinical isolate E. coli Gy-2/ApresErres
showed no differences (Table 1).
4. Conclusions
Synergistic or additive effects of AcDHP (G1/11)
with Ap or Er have been shown on E . coli K12LE140/
F’lac and E . coli Gy-1/ApsensErres but, not on E . coli
Gy-2/ApresErres. These effects of synergistic or additive
combinations are supported by additional experiments,
in which trimeprazine exhibited significant synergistic
antimicrobial activity when combined with either tri-
methoprim or sulfathiazole [11]; development of cross-
resistance by administration of non antibiotics with
antibiotics has also been repeated [12]. The present
paper clearly defines the effects of combinations of
AcDHP (G1/11) analogues with Ap or Er, which are of
some interest.
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